Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022		145,013,786
Beginning balance at Dec. 31, 2022	$ 339,310	$ 1	$ 951,946	$ (233)	$ (612,404)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	104,772		104,772
Exercise of stock options (in shares)		5,477,153
Exercise of stock options	17,996		17,996
Vesting of restricted stock units (in shares)		6,134,641
Vesting of restricted stock units	512	$ 1	511
Issuance of common stock under employee stock purchase plan (in shares)		1,029,344
Issuance of common stock under employee stock purchase plan	8,043		8,043
Shares withheld related to net share settlement of equity awards (in shares)		(488,564)
Shares withheld related to net share settlement of equity awards	(6,760)		(6,760)
Other comprehensive income (loss)	313			313
Net income (loss)	(107,294)				(107,294)
Ending balance (in shares) at Dec. 31, 2023		157,166,360
Ending balance at Dec. 31, 2023	356,892	$ 2	1,076,508	80	(719,698)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	98,408		98,408
Exercise of stock options (in shares)		3,141,652
Exercise of stock options	2,255		2,255
Vesting of restricted stock units (in shares)		6,839,969
Vesting of restricted stock units	202		202
Issuance of common stock under employee stock purchase plan (in shares)		946,694
Issuance of common stock under employee stock purchase plan	7,054		7,054
Shares withheld related to net share settlement of equity awards (in shares)		(4,405,276)
Shares withheld related to net share settlement of equity awards	$ (30,837)		(30,837)
Repurchases of common stock (in shares)	(16,205,119)	(16,205,119)
Repurchases of common stock	$ (151,201)	$ (1)	(151,200)
Other comprehensive income (loss)	(91)			(91)
Net income (loss)	(85,288)				(85,288)
Ending balance (in shares) at Dec. 31, 2024		147,484,280
Ending balance at Dec. 31, 2024	197,394	$ 1	1,002,390	(11)	(804,986)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	75,360		75,360
Exercise of stock options (in shares)		364,669
Exercise of stock options	75		75
Vesting of restricted stock units (in shares)		7,394,981
Issuance of common stock under employee stock purchase plan (in shares)		816,359
Issuance of common stock under employee stock purchase plan	4,175		4,175
Shares withheld related to net share settlement of equity awards (in shares)		(3,038,147)
Shares withheld related to net share settlement of equity awards	$ (20,316)		(20,316)
Repurchases of common stock (in shares)	(7,971,500)	(7,971,500)
Repurchases of common stock	$ (50,207)		(50,207)
Other comprehensive income (loss)	173			173
Net income (loss)	3,807				3,807
Ending balance (in shares) at Dec. 31, 2025		145,050,642
Ending balance at Dec. 31, 2025	$ 210,461	$ 1	$ 1,011,477	$ 162	$ (801,179)